• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by American Exceptionalism Acquisition Corp. A

    10/3/25 4:53:45 PM ET
    $AEXA
    Get the next $AEXA alert in real time by email
    8-K
    false 0002079173 0002079173 2025-09-29 2025-09-29
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    Form 8-K

     

     

    Current Report

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 29, 2025

     

     

    AMERICAN EXCEPTIONALISM ACQUISITION CORP. A

    (Exact name of registrant as specified in its charter)

     

     

    Commission file number: 001-42866

     

    Cayman Islands   98-1871331
    (State of incorporation)  

    (I.R.S. Employer

    Identification No.)

     

    506 Santa Cruz Ave., Suite 300

    Menlo Park, CA 94025

      94025
    (Address of principal executive offices)   (Zip Code)

    (650) 521-9007

    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol

     

    Name of each exchange

    on which registered

    Class A ordinary shares, $0.0001 par value per share   AEXA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 8.01

    Other Events.

    On September 29, 2025, American Exceptionalism Acquisition Corp. A (the “Company”) consummated its initial public offering (the “IPO”) of 34,500,000 Class A ordinary shares of the Company, par value $0.0001 per share (each, an “Ordinary Share”, and the Ordinary Shares sold in the IPO, the “Public Shares”), including the issuance of 4,500,000 Public Shares as a result of the underwriters’ exercise of their over-allotment option, at a price of $10.00 per Public Share, generating gross proceeds (before underwriting discounts and commissions and offering expenses) to the Company of $345,000,000.

    Substantially concurrently with the closing of the IPO, the Company completed the private sale of 175,000 Ordinary Shares (the “Private Placement Shares”) at a price of $10.00 per Private Placement Share to the Company’s sponsor, AEXA Sponsor LLC, generating gross proceeds to the Company of $1,750,000.

    A total of $345,000,000, comprised of proceeds from the IPO and the sale of the Private Placement Shares, was placed in a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. An audited balance sheet as of September 29, 2025 reflecting receipt of the proceeds upon consummation of the IPO and the sale of the Private Placement Shares has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit
    No.
      

    Description

    99.1    Audited Balance Sheet, as of September 29, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    AMERICAN EXCEPTIONALISM ACQUISITION CORP. A
    By:  

    /s/ Steven Trieu

      Steven Trieu
      Chief Executive Officer

    Dated: October 3, 2025

    Get the next $AEXA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEXA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AEXA
    SEC Filings

    View All

    SEC Form 10-K filed by American Exceptionalism Acquisition Corp. A

    10-K - American Exceptionalism Acquisition Corp. A (0002079173) (Filer)

    3/30/26 9:14:53 AM ET
    $AEXA

    Amendment: SEC Form SCHEDULE 13G/A filed by American Exceptionalism Acquisition Corp. A

    SCHEDULE 13G/A - American Exceptionalism Acquisition Corp. A (0002079173) (Subject)

    2/12/26 10:08:49 AM ET
    $AEXA

    SEC Form 10-Q filed by American Exceptionalism Acquisition Corp. A

    10-Q - American Exceptionalism Acquisition Corp. A (0002079173) (Filer)

    11/14/25 5:13:11 PM ET
    $AEXA

    $AEXA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Aexa Sponsor Llc was granted 175,000 units of Class A Ordinary Shares (SEC Form 4)

    4/A - American Exceptionalism Acquisition Corp. A (0002079173) (Issuer)

    12/30/25 4:56:07 PM ET
    $AEXA

    Amendment: SEC Form 3 filed by new insider Aexa Sponsor Llc

    3/A - American Exceptionalism Acquisition Corp. A (0002079173) (Issuer)

    12/30/25 4:52:39 PM ET
    $AEXA

    Amendment: SEC Form 3 filed by new insider Athwal Jas

    3/A - American Exceptionalism Acquisition Corp. A (0002079173) (Issuer)

    12/30/25 4:47:32 PM ET
    $AEXA